K D Kieburtz, R W Price, J J Sidtis, C Hall, M Grundman, C McLaren
{"title":"二腺苷在HIV痴呆患者中的初步研究。","authors":"K D Kieburtz, R W Price, J J Sidtis, C Hall, M Grundman, C McLaren","doi":"10.1300/j128v01n04_01","DOIUrl":null,"url":null,"abstract":"<p><p>In a pilot open-labeled study 10 subjects with AIDS dementia complex (ADC) were treated with didanosine. Only half of the subjects were able to complete the trial as a result of side effects. Five subjects exhibited improved performance on neuropsychological testing, but the mean change in performance in this small group was not statistically significant. The study suggests that this drug may have some value in ADC patients unable to tolerate other therapies, but that further study is needed to establish this firmly.</p>","PeriodicalId":73854,"journal":{"name":"Journal of neuro-AIDS","volume":"1 4","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Pilot Study of Didanosine in Patients with HIV Dementia.\",\"authors\":\"K D Kieburtz, R W Price, J J Sidtis, C Hall, M Grundman, C McLaren\",\"doi\":\"10.1300/j128v01n04_01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In a pilot open-labeled study 10 subjects with AIDS dementia complex (ADC) were treated with didanosine. Only half of the subjects were able to complete the trial as a result of side effects. Five subjects exhibited improved performance on neuropsychological testing, but the mean change in performance in this small group was not statistically significant. The study suggests that this drug may have some value in ADC patients unable to tolerate other therapies, but that further study is needed to establish this firmly.</p>\",\"PeriodicalId\":73854,\"journal\":{\"name\":\"Journal of neuro-AIDS\",\"volume\":\"1 4\",\"pages\":\"1-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of neuro-AIDS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1300/j128v01n04_01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuro-AIDS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1300/j128v01n04_01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pilot Study of Didanosine in Patients with HIV Dementia.
In a pilot open-labeled study 10 subjects with AIDS dementia complex (ADC) were treated with didanosine. Only half of the subjects were able to complete the trial as a result of side effects. Five subjects exhibited improved performance on neuropsychological testing, but the mean change in performance in this small group was not statistically significant. The study suggests that this drug may have some value in ADC patients unable to tolerate other therapies, but that further study is needed to establish this firmly.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
